<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68487</article-id><article-id pub-id-type="doi">10.7554/eLife.68487</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-233419"><name><surname>Pal</surname><given-names>Virender Kumar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233420"><name><surname>Agrawal</surname><given-names>Ragini</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233421"><name><surname>Rakshit</surname><given-names>Srabanti</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233422"><name><surname>Shekar</surname><given-names>Pooja</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233423"><name><surname>Murthy</surname><given-names>Diwakar Tumkur Narasimha</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233424"><name><surname>Vyakarnam</surname><given-names>Annapurna</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-173913"><name><surname>Singh</surname><given-names>Amit</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6761-1664</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Microbiology and Cell Biology</institution>, <institution>Indian Institute of Science</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff><aff id="aff2"><institution content-type="dept">CIDR</institution>, <institution>Indian Institute of Science</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff><aff id="aff3"><institution content-type="dept">BMCRI</institution>, <institution>Bangalore Medical College and Research Institute</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff><aff id="aff4"><institution content-type="dept">Internal Medicine</institution>, <institution>Bangalore Medical College and Research Institute</institution>, <addr-line><named-content content-type="city">Bangalore</named-content></addr-line>, <country>India</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-21373"><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name><role>Reviewing editor</role><aff><institution>Ulm University Medical Center</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>asingh@iisc.ac.in</email> (AS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>11</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e68487</elocation-id><history><date date-type="received"><day>17</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Pal et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Pal et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68487-v1.pdf"/><abstract><p>A fundamental challenge in HIV eradication is to understand how the virus establishes latency, maintains stable cellular reservoirs, and promotes rebound upon interruption of antiretroviral treatment (ART). Here, we discovered an unexpected role of the ubiquitous gasotransmitter hydrogen sulfide (H<sub>2</sub>S) in HIV latency and reactivation. We show that reactivation of HIV-1 is associated with down-regulation of the key H<sub>2</sub>S producing enzyme cystathionine-g-lyase (CTH) and reduction in endogenous H<sub>2</sub>S. Genetic silencing of CTH disrupts redox homeostasis, impairs mitochondrial function, and remodels the transcriptome of latent cells to trigger HIV reactivation. Chemical complementation of CTH activity using a slow-releasing H<sub>2</sub>S donor, GYY4137, suppressed HIV reactivation and diminished virus replication. Mechanistically, GYY4137 blocked HIV reactivation by inducing the Keap1-Nrf2 pathway, inhibiting NF-kB, and recruiting the epigenetic silencer, YY1, to the HIV promoter. In latently infected CD4<sup>+</sup> T cells from ART-suppressed human subjects, GYY4137 in combination with ART prevented viral rebound and improved mitochondrial bioenergetics. Moreover, prolonged exposure to GYY4137 exhibited no adverse influence on proviral content or CD4<sup>+</sup> T cell subsets, indicating that diminished viral rebound is due to a loss of transcription rather than a selective loss of infected cells. In summary, this work provides mechanistic insight into H<sub>2</sub>S-mediated suppression of viral rebound and suggests exploration of H<sub>2</sub>S donors to maintain HIV in a latent form.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Wellcome trust-DBT India Alliance</institution></institution-wrap></funding-source><award-id>IA/S/16/2/502700</award-id><principal-award-recipient><name><surname>Singh</surname><given-names>Amit</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001407</institution-id><institution>Department of Biotechnology, Ministry of Science and Technology, India</institution></institution-wrap></funding-source><award-id>BT/PR13522/COE/34/27/2015,BT/PR29098/Med/29/1324/2018,and BT/HRD/NBA/39/07/2018-19</award-id><principal-award-recipient><name><surname>Singh</surname><given-names>Amit</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001407</institution-id><institution>Department of Biotechnology, Ministry of Science and Technology, India</institution></institution-wrap></funding-source><award-id>22-0905-0006-05-987 436</award-id><principal-award-recipient><name><surname>Singh</surname><given-names>Amit</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Peripheral blood mononuclear cells (PBMCs) were collected from five aviremic HIV‐seropositive subjects on stable suppressive ART. All subjects provided signed informed consent approved by the Indian Institute of Science, and Bangalore Medical College and Research Institute review boards (IHEC No.‐ 3‐14012020).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2 and 5.</p></sec><supplementary-material><ext-link xlink:href="elife-68487-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>